During Medline’s first earnings call, the CEO outlined how recent import tariffs on steel and aluminum have driven up procurement costs for medical supplies, prompting consideration of price adjustments and supply chain diversification. He also revealed that Medline is planning a future IPO once debt targets are met and market conditions are deemed optimal, though no specific timeframe was provided.